Director, Marketing and Communications
Baylor Scott & White Research Institute
3310 Live Oak, Suite 501
Baylor Scott & White Research Institute
Dallas, TX 75204
Baylor Scott & Whiter Research Institute Mission Statement:
To improve the medical care and well-being of our community, nationally and internationally, through innovative research that is consistent with the mission, vision and values of Baylor Scott & White Health.
The Baylor Scott & White Research Institute is an affiliate of Baylor Scott & White Health, which offers 5.3 million patient encounters annually, 6,600 medical staff members and 49 hospitals that are owned, operated, joint-ventured or affiliated.
Baylor Scott & White Research Institute staffs approximately 600 employees in more than 243,000 square feet of research space. Award-winning scientists and medical professionals conduct more than 2,000 active research protocols, spanning more than 58 medical specialties.
Baylor Scott & White Research Institute's research is frequently published in major scientific journals and reported at medical and scientific meetings, generating issued and pending patents in immunotherapy, genomics, biomarkers, metabolomics, metabolic, cardiovascular disease and medical devices.
Because the system serves more than 800,000 people at medical centers in Dallas, Fort Worth, Garland, Grapevine, Irving, Plano, Waxahachie, Denton, Carrollton, Waco, Round Rock, Cedar Park, Brenham, College Station, Llano, Marble Falls, Taylor and Temple, we have a large and diverse pool of potential research participants.
As a leading clinical research institution, Baylor Scott & White Research Institute offers patients the opportunity to participate in clinical trials across a wide spectrum of medical specialties, including:
Through clinical research, investigators achieve advances in medicine and bring potential innovative therapies to patients at Baylor Scott & White Health facilities. Many of those clinical research studies conducted at Baylor Scott & White Research Institute have received national and international media attention, including the following research topics: hepatitis C treatment, instant noodles’ health impact and new devices in the NICU.
Baylor Scott & White Health recruits leading physicians and scientists to enhance its scientific base and provide advanced patient therapies. Research keeps physicians on the forefront of medical knowledge. Investigators at Baylor Scott & White Research Institute publish research findings in top-tier medical journals, such as Cell, Science, The New England Journal of Medicine, Transplantation and Lancet. Baylor Scott & White Health also publishes Baylor University Medical Center Proceedings, a quarterly research journal detailing research and clinical activities at Baylor Scott & White.
The institute staffs approximately 600 employees, including scientists, laboratory assistants and research coordinators. Michael A.E. Ramsay, M.D., serves as president of the Baylor Scott & White Research Institute.
The following medical centers, labs and facilities participate in research through Baylor Scott & White Research Institute:
Baylor Scott & White Research Institute supports more than 300 active clinical trial investigators, experienced in drug, device and vaccine trials and studies. Our Investigators specialize in the areas of allergy, asthma, autoimmunity, cardiology, bone marrow transplant, dermatology, endocrinology, gastroenterology, hepatology, immunology, infectious diseases, interventional radiology, metabolic disease, obstetrics/neonatology, nephrology, neurology, oncology, orthopedics, pulmonology, rheumatology, solid organ transplants and urology.
Baylor Scott & White Research Institute employs more than 600 employees, including scientists, laboratory assistants, research nurses, clinical research assistants and research coordinators. More than half of the research nurses and coordinators are Certified Clinical Research Coordinators. The research staff assists Baylor Scott & White Health investigators with coordinating and managing administrative and clinical aspects of investigational drug, device and other research trials and studies. The research staff has experience managing Phase I through Phase IV clinical trials and is thoroughly educated in federal regulations and institutional policies.
Baylor Scott & White Research Institute received Full Accreditation from the Association for the Accreditation of Human Research Programs (AAHRPP) in December of 2003 and received reaccreditation in 2015. The Office of Research Subject Protection at Baylor Scott & White Research Institute has responsibility for the three Institutional Review Boards (IRBs), two of which meet monthly and the third of which manages expedited and exempt studies.